![Pascal Touchon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pascal Touchon
Direttore/Membro del Consiglio presso
IPSEN
Patrimonio netto: 910 679 $ in data 31/05/2026
Profilo
Pascal Touchon is currently an Independent Director at MedinCell SA since 2025 and a Director at Ipsen SA since 2023.
Former roles include Chairman at Atara Biotherapeutics, Inc. from 2024 to 2025, and Director positions at Navigate BioPharma Services, Inc., Genoptix, Inc., Cogen Immune Medicine, Inc., Dantari, Inc., and Novartis Oncology, Inc. as SVP-Global Head Cell & Gene.
Education includes an MBA from INSEAD and a doctorate from Université Toulouse III - Paul Sabatier.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2025 | 77.955 ( 0,87% ) | 819 307 $ | 31/05/2026 | |
IPSEN SA 0% | 31/12/2025 | 500 ( 0% ) | 91 372 $ | 31/05/2026 |
Posizioni attive di Pascal Touchon
| Società | Posizione | Inizio |
|---|---|---|
| IPSEN | Direttore/Membro del Consiglio | 01/10/2023 |
| MEDINCELL S.A. | Direttore/Membro del Consiglio | 01/03/2025 |
Precedenti posizioni note di Pascal Touchon
| Società | Posizione | Fine |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Amministratore Delegato | 09/09/2024 |
Cogen Immune Medicine, Inc.
 Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Direttore/Membro del Consiglio | 01/02/2020 |
Navigate Biopharma Services, Inc.
 Navigate Biopharma Services, Inc. BiotechnologyHealth Technology Operates as a testing laboratory that designs biomarker solutions | Direttore/Membro del Consiglio | - |
Dantari, Inc.
 Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Direttore/Membro del Consiglio | - |
Genoptix, Inc.
 Genoptix, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine services | Direttore/Membro del Consiglio | - |
Formazione di Pascal Touchon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
33
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Genoptix, Inc.
Genoptix, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine services | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Toulouse III - Paul Sabatier
 Université Toulouse III - Paul Sabatier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedinCell SA
 MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Health Technology |
Navigate Biopharma Services, Inc.
Navigate Biopharma Services, Inc. BiotechnologyHealth Technology Operates as a testing laboratory that designs biomarker solutions | Health Technology |
Dantari, Inc.
Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Health Technology |
